hedamycin has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altieri, DC; Apontes, P; Beerman, T; Li, F; Liang, P; Ling, X; Pan, D; Song, L; Wu, J | 1 |
1 other study(ies) available for hedamycin and Colonic Neoplasms
Article | Year |
---|---|
Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity.
Topics: Anthraquinones; Apoptosis; Base Pairing; Base Sequence; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; DNA Footprinting; DNA, Neoplasm; HeLa Cells; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Molecular Sequence Data; Neoplasm Proteins; Polymerase Chain Reaction; Survivin; Transcription, Genetic | 2005 |